Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Web Exclusives
In the News
,
Lung Cancer
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Read More
FDA Approvals
,
Select Drug Profiles
Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
Venclexta FDA Approved for Patients with CLL
Read More
Letters to the Editor
,
In the News
Correspondence: Developing a Model Framework to Assess Cost of Therapy
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Infliximab Biosimilar for Multiple Indications
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B
Read More
FDA Approvals
,
In the News
,
Select Drug Profiles
FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers
Read More
Drug Updates
,
FDA Approvals
,
Select Drug Profiles
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
Read More
21
22
23
24
25
26
27
Page 24 of 37
Results 231 - 240 of 366